Hyperphosphatemia: a serious limiting factor preventing the possible benefit from intravenous calcitriol therapy

Nephron. 1999;82(1):77-8. doi: 10.1159/000045373.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Absorptiometry, Photon
  • Alkaline Phosphatase / blood
  • Bone Density
  • Calcitriol / administration & dosage
  • Calcitriol / therapeutic use*
  • Calcium / blood
  • Humans
  • Hyperparathyroidism / drug therapy*
  • Hyperparathyroidism / etiology*
  • Injections, Intravenous
  • Phosphates / blood*
  • Renal Dialysis* / adverse effects
  • Uremia / therapy*

Substances

  • Phosphates
  • Alkaline Phosphatase
  • Calcitriol
  • Calcium